(Q67899179)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827432%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

meta-analysis

0 references

title

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827432%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

4 December 2022

1 reference

4 December 2022

author name string

D. D. Von Hoff

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827432

4 December 2022

J. Turner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827432

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1827432

4 December 2022

publication date

1 February 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827432%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

http://link.springer.com/content/pdf/10.1007/BF00194562.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00194562/fulltext.html

4 December 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00194562

4 December 2022

1 reference

Investigational New Drugs

4 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827432%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827432%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827432%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

115-122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1827432%20AND%20SRC:MED&resulttype=core&format=json

The effect of measuring error on the results of therapeutic trials in advanced cancer

19 September 2019

cites work

1 reference

12 December 2020

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.

1 reference

12 December 2020

Activity of mitoxantrone in a human tumor cloning system

1 reference

12 December 2020

Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy

1 reference

12 December 2020

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

1 reference

12 December 2020

The National Cancer Institute antitumor drug discovery program, current and future perspectives: a commentary.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00194562

0 references

1 reference